Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine

Journal of Clinical Psychiatry

Volumn 61, Issue 5, 2000, Pages 349-355

  Brody, Arthur L ^a   Saxena, Sanjaya ^a   Fairbanks, Lynn A ^a   Alborzian, Shervin ^a   Demaree, Heath A ^a   Maidment, Karron M ^a   Baxter Jr , Lewis R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE;

ARTICLE; AVOIDANCE BEHAVIOR; CLINICAL ARTICLE; DEPRESSION; HOSTILITY; HUMAN; OBSESSION; PERSONALITY DISORDER; PRIORITY JOURNAL; SOCIAL DOMINANCE; TREATMENT OUTCOME;

EID: 0034087999     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0505     Document Type: Article

References (50)

1. Costa PT, McCrae RR. Personality in adulthood: a six-year longitudinal study of self-reports and spouse ratings on the NEO Personality Inventory. J Pers Soc Psychol 1988;54:853-863
2. Costa PT, McCrae RR. Set like plaster? evidence for the stability of adult personality. In: Heatherton TF, Weinberger HL, eds. Can Personality Change? Washington, DC: American Psychological Association; 1997: 21-40
3. Finn SE. Stability of personality self-ratings over 30 years: evidence for an age/cohort interaction. J Pers Soc Psychol 1986;50:813-818
4. Haan N, Millsap R, Hartka E. As time goes by: change and stability in personality over fifty years. Psychol Aging 1986;1:220-232
5. Cloninger CR. A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987;44:573-587
6. Chien AJ, Dunner DL. The Tridimensional Personality Questionnaire in depression: state versus trait issues. J Psychiatr Res 1996;30:21-27
7. Ricciardi JN, Baer L, Jenike MA, et al. Changes in DSM-III-R Axis II diagnoses following treatment of obsessive-compulsive disorder. Am J Psychiatry 1992;149:829-831
8. Allgulander C, Cloninger CR, Przybeck TR, et al. Changes on the temperament and character inventory after paroxetine treatment in volunteers with generalized anxiety disorder. Psychopharmacol Bull 1998;34: 165-166
9. Edwards DH, Kravitz EA. Serotonin, social status and aggression. Curr Opin Neurobiol 1997;7:812-819
10. Raleigh MJ, McGuire MT, Brammer GL, et al. Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys. Brain Res 1991;559:181-190
11. Kramer PD. Listening to Prozac. New York, NY: Viking; 1993
12. Coccaro EF, Kavoussi RJ. Neurotransmitter correlates of impulsive aggression. In: Stoff DM, Cairns RB, eds. Aggression and Violence. Hillsdale, NJ: Lawrence Erlbaum Associates; 1996:67-85
13. Fava M, Rosenbaum JF, Pava JA, et al. Anger attacks in unipolar depression, part 1: clinical correlates and response to fluoxetine treatment. Am J Psychiatry 1993;150:1158-1163
14. Fuller RW. The influence of fluoxetine on aggressive behavior. Neuropsychopharmacology 1996:14:77-81
15. Manuck SB, Flory JD, McCaffery JM, et al. Aggression, impulsivity and central nervous system serotonergic responsivity in a nonpatient sample. Neuropsychopharmacology 1998;19:287-299
16. Villalba C, Boyle PA, Caliguri EJ, et al. Effects of the selective serotonin reuptake inhibitor fluoxetine on social behaviors in male and female prairie voles (Microtus ochrogaster). Horm Behav 1997;32:184-191
17. Virkkunen M, Rawlings R, Tokola R, et al. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters and healthy volunteers. Arch Gen Psychiatry 1994;51:20-27
18. Mehlman PT, Higley JD, Faucher I, et al. Correlation of CSF 5-HIAA concentration with sociality and the timing of emigration in free-ranging primates. Am J Psychiatry 1995;152:907-913
19. Knutson B, Wolkowitz OM, Cole SW, et al. Serotonergic intervention selectively alters aspects of personality and social behavior in normal humans. Am J Psychiatry 1998;155:373-379
20. Cattell RB, Eber HW, Tatsuoka MM. Handbook for the Sixteen Personality Factor Questionnaire (16PF). Champaign, Ill: Institute for Personality and Ability Testing: 1970
21. Institute for Personality and Ability Testing. Administrator's Manual for the Sixteen Personality Factor Questionnaire. Champaign, Ill: Institute for Personality and Ability Testing; 1991
22. Cattell RB, Krug SE. The number of factors in the 16PF: a review of the evidence with special emphasis on methodological problems. Educ Psychol Meas 1986;46:509-522
23. Cattell RB. The 16-PF personality structure and Dr. Eysenck. J Soc Behav Pers 1986;1:153-160
24. Cattell RB. Constancy of global, second order personality factors over a twenty-year-plus period. Psychol Rep 1994;75:3-9
25. Cattell HE. Some comments on a factor analysis of the 16PF and the NEO personality inventory-revised. Psychol Rep 1995;77:1307-1311
26. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993;50:975-990
27. Eysenck HJ. Dimensions of personality: 16, 5, or 3? criteria for a taxonomic paradigm. Pers Individual Differences 1991;12:773-790
28. Eysenck HJ. The big five or giant three: criteria for a paradigm. In: Halverson CF, Kohnstamm GA, Martin RP, eds. The Developing Structure of Temperament and Personality From Infancy to Adulthood. Hillsdale, NJ: Lawrence Erlbaum Associates; 1994:37-51
29. Heath AC, Cloninger C, Martin NG. Testing a model for the genetic structure of personality: a comparison of the personality systems of Cloninger and Eysenck. J Pers Soc Psychol 1994;66:762-775
30. Freedman M, Sala M, Faraj G, et al. Psychological changes during thyrotoxicosis. Thyroidology 1993;5:25-28
31. Dobia B, McMurray NE. Applicability of learned helplessness to depressed women undergoing assertion training. Aust J Psychol 1985;37: 71-80
32. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia (SADS), Third Edition. New York, NY: Biometric Research, New York State Psychiatric Institute; 1977
33. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296
34. Hamilton M. Diagnosis and rating of anxiety. Br J Psychiatry 1969;3: 76-79
35. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1011
36. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, II: validity. Arch Gen Psychiatry 1989;46: 1012-1016
37. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
38. Bennie EH, Mullin JM, Martindale JJ. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression. J Clin Psychiatry 1995;56:229-237
39. Pigott TA, Seay SM. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Clin Psychiatry 1999; 60:101-105
40. Rudolph RL, Fabre LF, Feighner JP, et al. A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression. J Clin Psychiatry 1998;59:116-122
41. Hirschfeld RMA, Klerman GL, Clayton PJ, et al. Assessing personality: effects of depressive state on trait measurement. Am J Psychiatry 1983; 140:695-699
42. Clark LA, Watson D, Mineka S. Temperament, personality, and the mood and anxiety disorders. J Abnorm Psychol 1994;103:103-116
43. Enns MW, Cox BJ. Personality dimensions and depression: review and commentary. Can J Psychiatry 1997;42:274-284
44. Bagby RM, Joffe RT, Parker JDA, et al. Major depression and the five-factor model of personality. J Personal Disord 1995;9:224-234
45. Brown SL, Svrakic DM, Przybeck TR, et al. The relationship of personality to mood and anxiety states: a dimensional approach. J Psychiatr Res 1992;26:197-211
46. Andrews W, Parker G, Barrett E. The SSRI antidepressants: exploring their "other" possible properties. J Affect Disord 1998;49:141-144
47. Tallis F, Rosen K, Shafran R. Investigation into the relationship between personality traits and OCD: a replication employing a clinical population. Behav Res Ther 1996;34:649-653
48. Peselow ED, Sanfilipo MP, Fieve RR. Patients' and informants' reports of personality traits during and after major depression. J Abnorm Psychol 1994;103:819-824
49. Gunasekara NS, Noble S, Benfield P. Paroxetine: an update of its pharmacology and therapeutic use in depression and a review of its use in other disorders. Drugs 1998;55:85-120
50. Stokes PE, Holtz A. Fluoxetine tenth anniversary update: the progress continues. Clin Ther 1997;19:1135-1250